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Renal cell carcinoma with rhabdoid differentiation: A novel entity with immunohistochemical study
Editor, Renal cell carcinoma (RCC) with rhabdoid differentiation, also known as rhabdoid RCC (RRCC), is a rare neoplasm with an incidence of 3%-5%. [1, 2] It is an aggressive tumor and its rhabdoid morphology accounts as an independent risk factor for increased death rate in patients. [3] Hence, it is important to recognize it and look for in any conventional case of RCC.
Adult RRCC is currently recognized as any histologic type of RCC containing foci of high-grade malignant cells with rhabdoid morphology. [1, 2] Intense periodic acid-Schiff (PAS) positivity and immunohistochemistry (IHC) characteristic of RCC along with positive p53, high Ki-67 index can confirm the diagnosis of RRCC. [1, 4] We present two cases of 59-year-old and 65-year-old male patients with vague abdominal complaints and loss of appetite. On examination, both the patients had pallor and microscopic hematuria. Imaging revealed large renal mass occupying most of the right kidney in both the patients. Bone scan ruled out distant metastasis. Radical nephrectomy specimens were received for histopathological examination.
Grossly, in case 1, the kidney appeared irregularly enlarged, bosselated with intact capsule. Cut surface revealed a tumor measuring 12 cm × 10 cm × 5 cm [ Figure 1a ]. In case 2, externally, the kidney was bosselated with one area showing capsular breach [ Figure 2b ]. Cut surface showed a tumor mass measuring 10 cm × 9.5 cm × 4.5 cm [ Figure 2a ]. Both the tumors had variegated appearance composed of gray-yellow, hemorrhagic, cystic, and necrotic areas with interspersed solid gray-white areas. Surgical renal vein cut margins were free of tumor.
Microscopy of both the tumors showed similar picture. The tumor cells were arranged in compact trabecular, tubular, and diffuse sheets. Tumor cells in majority of the foci were optically clear and few with granular eosinophilic cytoplasm with large, vesicular, centrally placed nuclei and prominent nucleoli, separated by prominent arborizing vascular septae [ Figure 1b ]. Focally, the tumor cells were arranged in sheets and had rhabdoid morphology comprising large pleomorphic cells with abundant intensely eosinophilic cytoplasm and eccentrically placed hyperchromatic nuclei and perinuclear eosinophilic inclusions with absent prominent fibrovascular septa [ Figures 1c and 2d ]. PAS showed positive result in clear cell areas and intense positivity in rhabdoid areas [ Figure 1d ]. On IHC, the tumor cells showed immunoreactivity for CD10 [ Figure 2c ], pan-cytokeratin (pan-CK) [ Figure 1e ], epithelial membrane antigen (EMA), CD19, CK10, and vimentin in both the areas, but vimentin stained intensely in the rhabdoid areas [Figures 1f, 2e and f]. p53 showed nuclear immunoreactivity only in the rhabdoid areas. INI-1 immunoreactivity was preserved in clear cell and rhabdoid areas [ Figure 1d ]. Desmin, CK7, and CD117 were negative. Ki-67 labeling index (KLI) was 38%. The above findings confirmed the diagnosis of RRCC.
Pediatric rhabdoid tumor of the kidney, first described in 1978, is a rare but well-recognized aggressive malignancy. In adults, it is infrequent. [5] The occurrence of rhabdoid differentiation is known to be associated with carcinomas, sarcomas, and melanoma of various organs in adults. [2, 5] It represents clonal evolution in malignant tumors and aggressive behavior. [1, 3, 4] Adult RRCC is a novel rare entity, the incidence of which is not known clearly. In two different studies, the incidence documented was 7.4% and 5%, respectively. [1, 2] The descriptive term "rhabdoid" refers to tumor cells that morphologically resemble, but ultrastructurally and IHC differ from rhabdomyoblastic cells. [5] RRCC is defined as any histologic type of RCC containing foci of high-grade malignant cells with rhabdoid morphology, characterized by large cells with large eccentric vesicular nuclei, prominent nucleoli, globular eosinophilic paranuclear inclusion bodies, and abundant eosinophilic cytoplasm. [1, 2] The proportion of the rhabdoid areas in RRCC can vary from 1% to 90% of the tumor mass. [1, 5] Among kidney tumors, it is most common in clear cell RCC (ccRCC). [2, 4] In one study, rhabdoid differentiation was identified most frequently with ccRCC followed by papillary RCC and sarcomatoid RCC. [4] Grossly, ccRCC is classically golden yellow due to the high lipid content. In contrast, rhabdoid areas appear solid, homogenous gray white as they are glycogen rich, lipid deficient, and less vascular. [1, 2] RRCC tends to be larger tumors with an average size of 7.5-8.8 cm compared to ccRCC, which has an average size of 4-7 cm. [1, 2] In both our cases, the tumors were of large size (12.5 cm and 10 cm) with classical golden yellow areas of clear cell component and solid gray-white rhabdoid areas.
Microscopic Fuhrman nuclear grade of ccRCC is usually low whereas the presence of rhabdoid morphology in RRCC automatically changes the nuclear grade to Fuhrman Grade IV. [1, 3] Rhabdoid cells give intense PAS positivity due to the rich glycogen content. [1, 2] Our cases showed similar findings.
The significance of recognition of rhabdoid differentiation in ccRCC is still undergoing evaluation. [1] [2] [3] Most studies believe that RRCC is twice as likely to undergo extrarenal invasion, distant metastasis, and early death, as compared to conventional ccRCC. [1, 3] A study documents that rhabdoid differentiation is not independently associated with increased death rate, and hence suggest that rhabdoid differentiation should not be grouped together when assessing risk in a patient with Grade 4 RCC. [6] The International Society of Urological Pathology, 2012, has categorized RRCC as a high-grade tumor (Grade 4). [3, 6] It is worth mentioning that in the present study, the first case had no capsular or perinephric fat invasion. The second case had only capsular invasion. None of the two cases had bony metastasis.
RRCC shows identical immunoprofile of the underlying RCC such as CK19, pan-CK, EMA, CD10, and vimentin immunoreactivity in clear cell and rhabdoid areas. [1] Rhabdoid areas exhibit intense vimentin and pan-CK positivity. [1, 4] It stains negatively for desmin, CD7, and CD117. [4] The similar immunophenotype between the rhabdoid and nonrhabdoid tumoral foci supports the origin of the rhabdoid cells from the ccRCC areas. p53 nuclear positivity and KLI are higher in rhabdoid areas compared to clear cell areas. This indicates higher proliferative activity in rhabdoid areas and may also represent progression to aggressive biological behavior. [4] INI-1 gene mutation characteristic of pure rhabdoid tumor is not seen in RRCC, and hence it retains INI-1 immunoreactivity. [2, 7] Our experience from the present cases highlights the rarity of the lesion and importance of extensive sampling and IHC study in predicting clinical outcome. The knowledge about its origin, risk factors associated, and biological behavior is not yet clearly known. [1, 6] Hence, extensive studies need to be carried out to throw more light on the histogenesis and progression of this tumor. Editor, Epithelial ovarian carcinomas (EOCs) are aggressive tumors, which often present with advanced stage disease. Hence, such cases have a relatively poorer prognosis and survival rate. The use of neoadjuvant chemotherapy (NACT), followed by tumor reduction surgery, also called as interval debulking surgery, is considered as an alternative therapeutic regimen for selected patients harboring advanced stage EOC. [1] Till date, several studies have attempted to draw an association between NACT and the histology of residual tumor, its grade, stage with the prognosis. A tumor regression grading (TRG) score which is widely used in cancers of gastrointestinal tract, has not been formulated for ovarian carcinomas, till date.
cm, (b) photomicrograph showing tumor cells invading the capsule (H and E, ×100), (c) tumor cells showing membrane immunoreactivity for CD10 (×100), (d) tumor cells having rhabdoid morphology (H and E, ×100), (e) and vimentin showing cytoplasmic immunoreactivity in clear cell (×100) and (f) rhabdoid areas (×100)
Our aims of this study were to assess the pathological outcome in cases of EOCs, post-NACT and to assess the uniformity of grossing techniques in post-NACT-treated specimens.
All pathology reports of "in-house" operated cases of carcinoma ovary of 1 year duration (January 2011-December 2011) were retrieved from the medical records of our institution. A total of 162 cases of total abdominal hysterectomy with bilateral salpingo-oophorectomy and omentectomy, post-NACT-treated EOC were retrieved.
In 1 year, 162 cases of EOC received NACT. Before the induction of therapy, majority of the patients had undergone ascitic fluid examination (111/162), or a biopsy (29/162) or a fine needle aspiration cytology diagnosis (10/162). The median age-group of these patients was 52 years, the mean being 51.04 years. The following table shows the post-NACT residual tumor status and histological subtyping [ Table 1 ].
Among a total number of cases with residual tumors, serous adenocarcinomas formed the most frequent histopathological subtype (66.67%). Immunohistochemical (IHC) staining was performed in 16/162 cases, to further subtype the tumor (in post-NACT samples). Necrosis, inflammation, psammomatous calcification, foamy histiocytes, hemosiderin laden macrophages, and foreign body type giant cells constituted as therapy-related changes. Ovaries were submitted entirely in 48/162 cases (29.62%). Out of the 146 cases with residual tumor,
